TY - JOUR
T1 - Fenton reaction-induced renal carcinogenesis in Mutyh-deficient mice exhibits less chromosomal aberrations than the rat model
AU - Li, Guang Hua
AU - Akatsuka, Shinya
AU - Chew, Shan Hwu
AU - Jiang, Li
AU - Nishiyama, Takahiro
AU - Sakamoto, Akihiko
AU - Takahashi, Takashi
AU - Futakuchi, Mitsuru
AU - Suzuki, Hiromu
AU - Sakumi, Kunihiko
AU - Nakabeppu, Yusaku
AU - Toyokuni, Shinya
N1 - Funding Information:
This work was supported by JSPS KAKENHI Grant Number JP16K15257, JP24108008 and JP17H04064 to ST, JP2221S0001 to MF and HS, JP22221004 to YN and JP15H04298 to KS, and Private University Research Branding Project to ST. This work was partly performed in the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University. The BLS4 cell line was kindly provided by Dr. Tomoya Katakai (Niigata University, Niigata, Japan). We thank Jihoon Song (Nagoya University) for technical assistance.
Publisher Copyright:
© 2017 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd
PY - 2017/11
Y1 - 2017/11
N2 - Oxidative stress including iron excess has been associated with carcinogenesis. The level of 8-oxoguanine, a major oxidatively modified base in DNA, is maintained very low by three distinct enzymes, encoded by OGG1, MUTYH and MTH1. Germline biallelic inactivation of MUTYH represents a familial cancer syndrome called MUTYH-associated polyposis. Here, we used Mutyh-deficient mice to evaluate renal carcinogenesis induced by ferric nitrilotriacetate (Fe-NTA). Although the C57BL/6 background is cancer-resistant, a repeated intraperitoneal administration of Fe-NTA induced a high incidence of renal cell carcinoma (RCC; 26.7%) in Mutyh-deficient mice in comparison to wild-type mice (7.1%). Fe-NTA treatment also induced renal malignant lymphoma, which did not occur without the Fe-NTA treatment in both the genotypes. Renal tumor-free survival after Fe-NTA treatment was marginally different (P = 0.157) between the two genotypes. Array-based comparative genome hybridization analyses revealed, in RCC, the loss of heterozygosity in chromosomes 4 and 12 without p16INK A inactivation; these results were confirmed by a methylation analysis and showed no significant difference between the genotypes. Lymphomas showed a preference for genomic amplifications. Dlk1 inactivation by promoter methylation may be involved in carcinogenesis in both tumors. Fe-NTA-induced murine RCCs revealed significantly less genomic aberrations than those in rats, demonstrating a marked species difference.
AB - Oxidative stress including iron excess has been associated with carcinogenesis. The level of 8-oxoguanine, a major oxidatively modified base in DNA, is maintained very low by three distinct enzymes, encoded by OGG1, MUTYH and MTH1. Germline biallelic inactivation of MUTYH represents a familial cancer syndrome called MUTYH-associated polyposis. Here, we used Mutyh-deficient mice to evaluate renal carcinogenesis induced by ferric nitrilotriacetate (Fe-NTA). Although the C57BL/6 background is cancer-resistant, a repeated intraperitoneal administration of Fe-NTA induced a high incidence of renal cell carcinoma (RCC; 26.7%) in Mutyh-deficient mice in comparison to wild-type mice (7.1%). Fe-NTA treatment also induced renal malignant lymphoma, which did not occur without the Fe-NTA treatment in both the genotypes. Renal tumor-free survival after Fe-NTA treatment was marginally different (P = 0.157) between the two genotypes. Array-based comparative genome hybridization analyses revealed, in RCC, the loss of heterozygosity in chromosomes 4 and 12 without p16INK A inactivation; these results were confirmed by a methylation analysis and showed no significant difference between the genotypes. Lymphomas showed a preference for genomic amplifications. Dlk1 inactivation by promoter methylation may be involved in carcinogenesis in both tumors. Fe-NTA-induced murine RCCs revealed significantly less genomic aberrations than those in rats, demonstrating a marked species difference.
UR - http://www.scopus.com/inward/record.url?scp=85032732348&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032732348&partnerID=8YFLogxK
U2 - 10.1111/pin.12598
DO - 10.1111/pin.12598
M3 - Article
C2 - 29027306
AN - SCOPUS:85032732348
SN - 1320-5463
VL - 67
SP - 564
EP - 574
JO - Acta Pathologica Japonica
JF - Acta Pathologica Japonica
IS - 11
ER -